These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28437608)

  • 21. Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling.
    Ivanov IE; Wright AV; Cofsky JC; Aris KDP; Doudna JA; Bryant Z
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5853-5860. PubMed ID: 32123105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR Mediated Genome Engineering and its Application in Industry.
    Kaboli S; Babazada H
    Curr Issues Mol Biol; 2018; 26():81-92. PubMed ID: 28879858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR-Cas9 Structures and Mechanisms.
    Jiang F; Doudna JA
    Annu Rev Biophys; 2017 May; 46():505-529. PubMed ID: 28375731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leveraging QM/MM and Molecular Dynamics Simulations to Decipher the Reaction Mechanism of the Cas9 HNH Domain to Investigate Off-Target Effects.
    Maghsoud Y; Jayasinghe-Arachchige VM; Kumari P; Cisneros GA; Liu J
    J Chem Inf Model; 2023 Nov; 63(21):6834-6850. PubMed ID: 37877218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guide RNA engineering for versatile Cas9 functionality.
    Nowak CM; Lawson S; Zerez M; Bleris L
    Nucleic Acids Res; 2016 Nov; 44(20):9555-9564. PubMed ID: 27733506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR-CAS9 D10A nickase target-specific fluorescent labeling of double strand DNA for whole genome mapping and structural variation analysis.
    McCaffrey J; Sibert J; Zhang B; Zhang Y; Hu W; Riethman H; Xiao M
    Nucleic Acids Res; 2016 Jan; 44(2):e11. PubMed ID: 26481349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of RNA Binding Partners of CRISPR-Cas Proteins in Prokaryotes Using RIP-Seq.
    Sharma S; Sharma CM
    Methods Mol Biol; 2022; 2404():111-133. PubMed ID: 34694606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.
    Zetsche B; Gootenberg JS; Abudayyeh OO; Slaymaker IM; Makarova KS; Essletzbichler P; Volz SE; Joung J; van der Oost J; Regev A; Koonin EV; Zhang F
    Cell; 2015 Oct; 163(3):759-71. PubMed ID: 26422227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. All-in-One CRISPR-Cas9/FokI-dCas9 Vector-Mediated Multiplex Genome Engineering in Cultured Cells.
    Sakuma T; Sakamoto T; Yamamoto T
    Methods Mol Biol; 2017; 1498():41-56. PubMed ID: 27709568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.
    Sternberg SH; Redding S; Jinek M; Greene EC; Doudna JA
    Nature; 2014 Mar; 507(7490):62-7. PubMed ID: 24476820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
    Yang H; Patel DJ
    Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR-Cas orthologues and variants: optimizing the repertoire, specificity and delivery of genome engineering tools.
    Cebrian-Serrano A; Davies B
    Mamm Genome; 2017 Aug; 28(7-8):247-261. PubMed ID: 28634692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A DNA unwinding equilibrium serves as a checkpoint for CRISPR-Cas12a target discrimination.
    Singh J; Liu KG; Allen A; Jiang W; Qin PZ
    Nucleic Acids Res; 2023 Sep; 51(16):8730-8743. PubMed ID: 37522352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.
    Pausch P; Müller-Esparza H; Gleditzsch D; Altegoer F; Randau L; Bange G
    Mol Cell; 2017 Aug; 67(4):622-632.e4. PubMed ID: 28781236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-Cas9 bends and twists DNA to read its sequence.
    Cofsky JC; Soczek KM; Knott GJ; Nogales E; Doudna JA
    Nat Struct Mol Biol; 2022 Apr; 29(4):395-402. PubMed ID: 35422516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR/Cas9 Technology in Translational Biomedicine.
    Leonova EI; Gainetdinov RR
    Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural roles of guide RNAs in the nuclease activity of Cas9 endonuclease.
    Lim Y; Bak SY; Sung K; Jeong E; Lee SH; Kim JS; Bae S; Kim SK
    Nat Commun; 2016 Nov; 7():13350. PubMed ID: 27804953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery.
    Lin S; Staahl BT; Alla RK; Doudna JA
    Elife; 2014 Dec; 3():e04766. PubMed ID: 25497837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.